Companies: 10,795·Total market cap: $144.5T
CSL Limited

CSL Limited

CMXHFOTCHealthcare● Active
$70.72
+$0.18(+0.26%)
Market Cap$33.9B
P/E Ratio
52W High$184.09
52W Low$63.99
Overview

CSL Limited(CMXHF)股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · CMXHF · 截至 Jun 8, 2026

关键指标

EPS (TTM)$8.65cmxhf eps ttm · cmxhf earnings per shareEarnings history
PE Ratio (TTM)8.2×cmxhf pe ratio ttm · cmxhf price to earningsPE Ratio deep dive
Revenue (TTM)$30.7Bcmxhf revenue ttm · cmxhf annual revenueFull revenue history
Dividend Yield2.95%does cmxhf pay dividends · cmxhf dividend yieldDividend history
Shares Outstanding484.0Mcmxhf shares outstanding · cmxhf floatShares outstanding history
Next EarningsAug 18, 2026Est.cmxhf earnings date · cmxhf next earningsEarnings history

财务快照

完整财报
FY 2025Revenue$15.43B▲ +4.26% YoY
202320242025
csl limited revenue · cmxhf revenue 2025
FY 2025Net Income$3.00B▲ +13.63% YoY
202320242025
csl limited net income · cmxhf profit 2025
FY 2025EPS$6.20▲ +13.35% YoY
202320242025
cmxhf eps · csl limited earnings per share 2025
TTM:Revenue: $30.65BNet Income: $4.19BEPS: $8.65View income statement →

股票表现

完整历史
1D+0.26%
1W+7.15%
1M-18.71%
3M-28.20%
YTD-38.77%
1Y-56.40%
5Y-69.05%

关于 CSL Limited

CEOGordon Naylor DipCompSc
IPO DateNov 18, 2005
Employees32,698
CountryAU
Websitecsl.com.au

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and int…

what is csl limited · cmxhf stock overview · csl limited company profile · who is csl limited ceo · cmxhf OTC · csl limited headquarters · csl limited business segments

关于股票概览与关键数据

CSL Limited(CMXHF)是 Biotechnology 行业的 Healthcare 类公司,于 Nov 18, 2005 在 OTC 上市。截至最近交易日,CMXHF 股价为 $70.72,市值约为 $33.9B。过去12个月累计回报 -56.40%,年初至今回报 -38.77%。

2025 财年 CSL Limited 营收 $15.4B。完整财务数据(营收历史、盈利、资产负债表)请使用上方标签页。

常见问题

截至最近一个交易日,CSL Limited(CMXHF)股价为 $70.72,在 OTC 上市,52周区间为 $63.99 – $184.09。

CMXHF 最新股价CMXHF quote todaylive ticker 实时行情
数据来源:Financial Modeling Prep最后更新:Jun 8, 2026本内容不构成投资建议